RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC, built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
2R44CA213782-02 Department of Health and Human Services $1,868,036 SBIR · Phase II 2019-09-17
1R43CA228776-01A1 Department of Health and Human Services $299,995 SBIR · Phase I 2018-09-01
1R43CA224643-01A1 Department of Health and Human Services $293,774 SBIR · Phase I 2018-04-01
1R43CA213782-01 Department of Health and Human Services $431,959 SBIR · Phase I 2017-03-02
75N91019C00040 Department of Health and Human Services $1,999,796 SBIR · Phase II
75N91019C00047 Department of Health and Human Services $299,275 SBIR · Phase I

Frequently asked questions

How many SBIR/STTR awards has RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC won?

RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC has won 6 SBIR/STTR awards worth $5,192,835 in the public federal award records SBIR Signal tracks, including 4 Phase I and 2 Phase II award(s).

Which agencies fund RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC?

RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC's awards come from 1 agency on record; its top funder is Department of Health and Human Services.

What technology areas does RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC work in?

Based on its award history, RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC works in a range of technology areas.

How do I find firms similar to RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.